tiprankstipranks
aTyr Pharma (ATYR)
NASDAQ:ATYR

aTyr Pharma (ATYR) Financial Statements

1,791 Followers

aTyr Pharma Financial Overview

aTyr Pharma's market cap is currently ―. The company's EPS TTM is $-0.903; its P/E ratio is -1.82; aTyr Pharma is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 235.00K-$ 353.00K--
Gross Profit$ 235.00K-$ 353.00K--
EBIT$ -16.64M$ -15.96M$ -12.62M$ -12.34M$ -11.95M
EBITDA$ -15.87M$ -15.55M$ -11.62M$ -12.64M$ -11.62M
Net Income Common Stockholders$ -15.49M$ -14.76M$ -11.34M$ -12.30M$ -11.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 84.50M$ 98.17M$ 102.13M$ 108.58M$ 114.39M
Total Assets$ 113.24M$ 120.67M$ 125.07M$ 132.73M$ 136.84M
Total Debt$ 14.13M$ 15.10M$ 15.22M$ 15.39M$ 14.29M
Net Debt$ -70.37M$ -83.07M$ -86.91M$ -93.19M$ -100.10M
Total Liabilities$ 28.97M$ 30.18M$ 26.87M$ 26.70M$ 27.14M
Stockholders Equity$ 84.48M$ 90.68M$ 98.39M$ 106.26M$ 109.88M
Cash Flow-
Free Cash Flow$ -22.40M$ -11.08M$ -10.12M$ -14.39M$ -1.84M
Operating Cash Flow$ -22.38M$ -11.06M$ -9.56M$ -12.01M$ -590.00K
Investing Cash Flow$ -1.36M$ 17.82M$ 4.38M$ -4.16M$ -38.17M
Financing Cash Flow$ 7.73M$ 6.03M$ 2.68M$ 8.02M$ 49.50M
Currency in USD

aTyr Pharma Earnings and Revenue History

aTyr Pharma Debt to Assets

aTyr Pharma Cash Flow

aTyr Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis